| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |